ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.

Hilary A Kenny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.